首页> 外文期刊>Journal of the American College of Surgeons >The predictive value of laboratory findings in patients with primary hyperparathyroidism.
【24h】

The predictive value of laboratory findings in patients with primary hyperparathyroidism.

机译:实验室检查结果对原发性甲状旁腺功能亢进症患者的预测价值。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Despite extensive preoperative imaging and intraoperative gadgetry onus of identification and resection remains with the surgeon in the operating room. We pondered the relative usefulness of routine laboratory studies to the surgeon as predictive guides to the intraoperative findings in patients with primary hyperparathyroidism (HPT). STUDY DESIGN: Pre- and postoperative laboratory data were analyzed in 166 consecutive patients (1998 to 1999) undergoing successful cervical exploration for sporadic primary HPT and were correlated with the pathologic findings. Patients with secondary HPT, multiple endocrine neoplasia, familial HPT, and parathyroid carcinoma were not included in this study. RESULTS: One hundred eighteen women and 48 men (mean age = 63 years) with parathyroid adenoma (n = 155) and sporadic hyperplasia (n = 11) were evaluated. Mean parathormone (PTH) levels varied little with the pathology: adenoma = 9.6 pmol/L and hyperplasia = 10.2 pmol/L (p > 0.05). In patients with parathyroid adenoma, analysis of preoperative measures showed a positive correlation (r = 0.48, p < 0.0001) with PTH and gland weight. The correlation appeared to be the strongest in the tails of the distribution; in 22 of 23 (96%) cases with PTH levels lower than 6 pmol/L, the offending lesion or lesions were less than 400 mg; in all six cases with PTH levels higher than 18.0 pmol/L, the abnormal gland or glands weighed more than 800 mg. PTH levels between 6 and 18 pmol/L revealed mean adenoma weight of 757 mg (median = 420 mg; range = 50 to 5,500 mg). CONCLUSIONS: Extreme values of PTH in patients with single-gland parathyroid disease alert the surgeon to the likelihood of small or large parathyroid adenomas. Laboratory studies do not differentiate adenoma from hyperplasia, nor do they pinpoint the size of abnormal glands with moderate-range PTH values.
机译:背景:尽管术前进行了大量的影像学检查和术中小工具,外科医生仍在手术室进行鉴别和切除。我们考虑了常规实验室研究对外科医生的相对有用性,作为对原发性甲状旁腺功能亢进症(HPT)患者术中发现的预测性指导。研究设计:分析了166例连续(1998年至1999年)因散发性原发性HPT成功进行宫颈探查的患者的术前和术后实验室数据,并将其与病理结果相关联。继发性HPT,多发性内分泌肿瘤,家族性HPT和甲状旁腺癌的患者不包括在本研究中。结果:118名女性和48名男性(平均年龄= 63岁)患有甲状旁腺腺瘤(n = 155)和偶发性增生(n = 11)。平均副激素(PTH)水平随病理变化不大:腺瘤= 9.6 pmol / L,增生= 10.2 pmol / L(p> 0.05)。在甲状旁腺腺瘤患者中,术前措施分析显示与甲状旁腺激素和腺体重量呈正相关(r = 0.48,p <0.0001)。在分布的尾部,相关性似乎最强。在PTH水平低于6 pmol / L的23例患者中,有22例(96%)的病变或病变小于400 mg;在所有六种PTH高于18.0 pmol / L的病例中,异常腺或腺体的重量均超过800 mg。 PTH水平在6至18 pmol / L之间时,表明腺瘤平均重量为757 mg(中位数= 420 mg;范围= 50至5500 mg)。结论:单腺甲状旁腺疾病患者的PTH极值使外科医生意识到甲状旁腺腺瘤小或大的可能性。实验室研究没有将腺瘤与增生区分开,也没有用中等范围的PTH值来查明异常腺的大小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号